Drug profile · INN
ociperlimab
ociperlimab is a t-cell immunoreceptor with ig and itim domains inhibitor.
NMPA: clinical trials
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — ociperlimab
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.70
Quick answer
ociperlimab is a t-cell immunoreceptor with ig and itim domains inhibitor.
Key facts
INN ociperlimab
Mechanism T-cell immunoreceptor with Ig and ITIM domains inhibitor
Target T-cell immunoreceptor with Ig and ITIM domains
Mechanism of action
T-cell immunoreceptor with Ig and ITIM domains inhibitor
Primary target: T-cell immunoreceptor with Ig and ITIM domains
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Pipeline programs
Frequently asked questions
What is ociperlimab?
ociperlimab is a t-cell immunoreceptor with ig and itim domains inhibitor.